Epigenetic modifications in trinucleotide repeat diseases

Marguerite V. Evans-Galea*, Anthony J. Hannan, Nissa Carrodus, Martin B. Delatycki, Richard Saffery

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

40 Citations (Scopus)


Accumulating evidence supports the important role for epigenetic changes in modulating clinical parameters of complex disorders, including neurodegenerative disease. Several conditions, including fragile X syndrome and Huntington's disease are caused by trinucleotide repeat (TNR) expansions in or near specific genes. Highlighting the link between epigenetic disruption and disease phenotype, recent studies have established significant correlations between clinical features, expansion size, gene expression, the chromatin profile, and DNA methylation in regions surrounding the TNR. Given the debilitating and sometimes fatal consequences of TNR disorders, understanding how an altered epigenetic profile impacts clinical outcome warrants further attention, and could provide key insights for developing novel epigenetic therapies and biomarkers. This review presents the current evidence of epigenetic changes in several TNR diseases.

Original languageEnglish
Pages (from-to)655-663
Number of pages9
JournalTrends in Molecular Medicine
Issue number11
Publication statusPublished - Nov 2013
Externally publishedYes


  • DNA expansions
  • DNA methylation
  • Histone modification
  • Neurodegenerative disease


Dive into the research topics of 'Epigenetic modifications in trinucleotide repeat diseases'. Together they form a unique fingerprint.

Cite this